Couldn’t have had a better first in-person #IDWeek! So invigorating seeing colleagues and mentors in action (Yi Guo Mei Chang Priya Nori MD, FSHEA, FIDSA Montefiore & Einstein ID), getting the chance to present this past year’s hard work, and being brought up to date on the latest discoveries!

What do we all think of remdesivir for inpts at this point, #IDTwitter? When the RDV RCT evidence is pre-vax/pre-Delta&Omicron, do NIH RDV inpatient treatment guideline recs have merit today? Just save it for sx pts on supp O2 and either unvax or highly immunosuppressed?

Hmm…M. kansasii cavitary PNA with AST results for two consecutive sputum cx: both rifampin R (MICs 2 and 4) but rifabutin S (MICs =<.12, 0.25). Do you trust rifabutin as the 3rd drug (etham + azithro)? Switch rif for moxi (yuck) per NTM guidelines? Rifabutin + a 4th? #idtwitter

Results: -7/9 - BCIDP (+) Recommendation: Repeat at next visit in 6 years. We will sign off now. Thank you for this interesting consult.